- English
- Esta página
- Página inicial
- Arabic (اللغة العربية)
- Chinese (简体中文)
- French (Français)
- Haitian Creole (Kreyòl Ayisyen)
- Hindi (जानकारी)
- Korean (한국어)
- Polish (język polski)
- Portuguese (Português)
- Russian (Русский)
- Spanish (Español)
- Tagalog (Tagalog)
- Ukrainian (Українська)
- Vietnamese (Tiếng Việt)
- All Languages
Español
PDFs by language
Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Chat live online
Select the Live Chat button at the bottom of the page
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through video calls and online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
- Referrals to patient-related programs or resources
- Donations, website, or event-related assistance
- Tobacco-related topics
- Volunteer opportunities
- Cancer Information
For medical questions, we encourage you to review our information with your doctor.
Research We Fund: Extramural Discovery Science
-
- Peer Review Committee for Experimental Therapeutics (ET)
- Peer Review Committee for DNA Mechanisms in Cancer (DMC)
- Peer Review Committee for Institutional Research Grants (IRG)
- Peer Review Committee for RNA Mechanisms in Cancer (RMC)
- Peer Review Committee for Tumor Biochemistry and Endocrinology (TBE)
- Peer Review Committee for Cancer Cell Biology (CCB)
- Peer Review Committee for Cancer Detection and Progression (CDP)
- Peer Review Committee for Cancer Prevention, Screening, and Health Promotion (CPSH)
- Peer Review Committee for Healthcare Outcomes, Policy, and Systems Research (HOPS)
- Peer Review Committee for Mission Boost Grants
- Peer Review Committee for Immunology and Blood Cell Development (IBCD)
- Peer Review Committee for Treatment, Palliative Care, and Survivorship Research
- Council for Extramural Grants
- Stakeholder Participation on Grant Peer Review Committees
- Peer Review Committee for Metastasis and Microenvironment (MM)
- Peer Review Committee for Clinical Studies and Clinical Trials
- American Cancer Society Research and Clinical Research Professors
Peer Review Committee for Cancer Detection and Progression (CDP)
Areas Reviewed
- Biomarker identification and pre-clinical development, including liquid biopsy and molecular imaging
- Pre-clinical modeling to identify factors (such as microbiota, pathogens, nutrition, metabolism, oxygen levels, oncogenes, and tumor suppressor genes) and their mechanisms of action contributing to cancer progression
- Mechanisms of therapeutic response, including tumor evolution and treatment resistance
- Mechanisms of treatment-associated morbidities
Peer Review Committee Members
Co-chair, Vera Tarakanova, PhD, Medical College of Wisconsin
Co-chair, Christopher Willey, MD, PhD, University of Alabama
Stakeholder, Karen Dupske
Stakeholder, Miguel Melendez
Grace Chen, MD, PhD, University of Michigan
Claudette St. Croix, PhD, University of Pittsburgh
Lukas Dow, PhD, Weill Cornell Medicine
Rebecca Leary, PhD, Novartis
James Robinson, PhD, University of Minnesota
Mala Shanmugam, PhD, Emory University
David Soto-Pantoja, PhD, Wake Forest University
Shannon Stott, PhD, Massachusetts General Hospital
Wei Qiu, PhD, Loyola University
Xuehong Zhang, MBBS, ScD, Harvard University